title: Effects of oral steroids on immunoglobulins in bronchoalveolar lavage fluid in active sarcoidosis.
abstract: Immunoglobulin (Ig) levels increase in the lower respiratory tract of patients with pulmonary sarcoidosis. We evaluated the effects of prednisone therapy upon Ig concentrations in bronchoalveolar lavage (BAL) fluid of ten patients with active disease (greater than 30% T-lymphocytes in BAL and positive 67Gallium (67Ga) lung scan). Therapy significantly lowered T-lymphocyte percentages in BAL and 67Ga lung scan indices and was followed by a slight improvement of the studied functional parameters. Biochemical analysis of BAL showed a significant decrease of both IgG/albumin (baseline 1.24 +/- 0.21; after therapy 0.40 +/- 0.12) and IgA/albumin (baseline 0.55 +/- 0.07; after therapy 0.14 +/- 0.03) ratios in all patients. Conversely, comparisons of IgM/albumin ratios did not show any change over the study period (baseline 0.05 +/- 0.01; after therapy 0.06 +/- 0.03). Thus oral steroid treatment suppresses the alveolitis of pulmonary sarcoidosis, as shown not only by the reduction of lung T-cells and 67Ga lung uptake, but also by the decreased Ig levels in the alveolar spaces.
authors.affiliation: Consiglio Nazionale delle Ricerche-Istituto di Fisiopatologia Respiratoria, Palermo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Spatafora
authors.forename: A
authors.initials: A
authors.lastname: Mirabella
authors.forename: G A
authors.initials: GA
authors.lastname: Rossi
authors.forename: A
authors.initials: A
authors.lastname: Bonanno
authors.forename: L
authors.initials: L
authors.lastname: Riccobono
authors.forename: A
authors.initials: A
authors.lastname: Merendino
authors.forename: V
authors.initials: V
authors.lastname: Bellia
authors.forename: G
authors.initials: G
authors.lastname: Bonsignore
mesh_terms: D000328:Adult; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis* / Q000166:cytology; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D012507:Sarcoidosis / Q000188:drug therapy*; D013601:T-Lymphocytes / Q000145:classification
chemical_list: D007136:Immunoglobulins; D011241:Prednisone